InvestorsHub Logo
Followers 68
Posts 506
Boards Moderated 0
Alias Born 08/14/2020

Re: None

Sunday, 11/15/2020 5:11:07 AM

Sunday, November 15, 2020 5:11:07 AM

Post# of 44690
"On 28 August 2006, orphan designation (EU/3/06/395) was granted by the European Commission to mondoBIOTECH Laboratories, Lichtenstein, for Aviptadil for the treatment of acute lung injury."
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu306395


BTW have you seen the xrays from the latest PR ... They are not subjective and it is blatantly obvious at what RLF-100(Aviptadil) does. There is NO OTHER THERAPY that has that kind of results otherwise we would have seen THEIR images.

It is coming...

Best,
JB

Disclaimer

All of my posts are just my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. I post my own personal thoughts and information that I have found regarding positions that I am invested in.